Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find the cash to take its lipid nanoparticle tech into the clinic.
https://www.fiercebiotech.com/biotech/generation-jettisons-90-employees-due-lack-time-cash-develop-autoimmune-tech